U.S. Physical Therapy acquires 12-clinic practice, expands to 45 states

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

U.S. Physical Therapy, Inc. acquired a 67% equity interest in a twelve-clinic practice effective July 1, 2026, expanding its footprint to 45 states. The practice generates 112,000 annual visits and $12 million in annual revenue.

powered bylight_fuzz_icon
44540765

*this image is generated using AI for illustrative purposes only.

U.S. Physical Therapy, Inc. has acquired a 67% equity interest in a twelve-clinic physical therapy practice, expanding its operational footprint to 45 states. The acquisition, effective July 1, 2026, includes a practice that currently generates approximately 112,000 annual visits and $12 million in annual revenue. The remaining 33% equity interest is retained by the current owners.

Strategic Expansion

This transaction marks U.S. Physical Therapy's entry into a new state, increasing its presence from 44 to 45 states. Graham Reeve, Chief Operating Officer-West, stated that the expansion represents an important step in the company's continuing growth. He emphasized that the new partners are known for delivering exceptional clinical care and building trusted relationships within their communities.

Operational Metrics

The acquired practice contributes significant scale to the company's national network. The following table outlines the key operational metrics of the newly acquired entity:

Metric Value
Clinics Acquired 12
Annual Visits 112,000
Annual Revenue $12 million
USPH Equity Interest 67%

Company Overview

Founded in 1990, U.S. Physical Therapy, Inc. owns and/or manages 795 outpatient physical therapy clinics across 45 states. The company provides preventative and post-operative care for orthopedic-related disorders, sports-related injuries, and neurologically related injuries. Additionally, U.S. Physical Therapy operates an industrial injury prevention business offering onsite services such as injury prevention, rehabilitation, and ergonomic assessments.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will U.S. Physical Therapy integrate the retained 33% equity owners into its operational framework?

Does this acquisition signal a shift in strategy toward entering new geographic markets rather than consolidating existing ones?

What are the projected financial synergies and cost savings from scaling this twelve-clinic practice?

like20
dislike

Citizens reiterates Market Outperform on US Physical Therapy

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Citizens analyst Constantine Davides has reiterated a Market Outperform rating for US Physical Therapy, maintaining a price target of $98.

powered bylight_fuzz_icon
43855306

*this image is generated using AI for illustrative purposes only.

Citizens analyst Constantine Davides has reaffirmed a Market Outperform rating for US Physical Therapy, maintaining a price target of $98. The rating reiteration signals continued confidence in the company's performance potential.

The analyst's stance supports the stock's current market trajectory, highlighting the firm's positive outlook. US Physical Therapy is listed on the NYSE under the ticker symbol USPH.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What upcoming catalysts could drive US Physical Therapy's stock toward the $98 price target?

How might changes in healthcare policy impact the company's growth trajectory?

What are the key risks that could challenge the analyst's optimistic outlook?

like19
dislike